N-(cyclopentylmethyl)-N-[[3-[2-[3-(3-fluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]ethanamine;2-[3-(3,5-difluorophenyl)propyl]-4-[3-[(2,3-dimethylpiperazin-1-yl)methyl]phenyl]pyrimidine;N-[[3-[2-[3-(3,5-difluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]-N-ethyl-2-piperazin-1-ylethanamine;N-ethyl-N-[[3-[2-[3-(3-methoxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;3-[1-[[3-[2-[3-(4-hydroxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperazin-2-yl]propanoic acid;2-methoxy-5-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol

C163H199F5N24O6 — CID 159016376

IUPACN-(cyclopentylmethyl)-N-[[3-[2-[3-(3-fluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]ethanamine;2-[3-(3,5-difluorophenyl)propyl]-4-[3-[(2,3-dimethylpiperazin-1-yl)methyl]phenyl]pyrimidine;N-[[3-[2-[3-(3,5-difluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]-N-ethyl-2-piperazin-1-ylethanamine;N-ethyl-N-[[3-[2-[3-(3-methoxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;3-[1-[[3-[2-[3-(4-hydroxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperazin-2-yl]propanoic acid;2-methoxy-5-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol
SMILESCC1NCCN(Cc2cccc(-c3ccnc(CCCc4cc(F)cc(F)c4)n3)c2)C1C.CCN(CCN1CCNCC1)Cc1cccc(-c2ccnc(CCCc3cc(F)cc(F)c3)n2)c1.CCN(Cc1cccc(-c2ccnc(CCCc3cccc(F)c3)n2)c1)CC1CCCC1.CCN(Cc1cccc(-c2ccnc(CCCc3cccc(OC)c3)n2)c1)C1CCNCC1.COc1ccc(CCCc2nccc(-c3cccc(CN4CCNC[C@@H]4C)c3)n2)cc1O.O=C(O)CCC1CNCCN1Cc1cccc(-c2ccnc(CCCc3ccc(O)cc3)n2)c1
InChIInChI=1S/C28H35F2N5.C28H34FN3.C28H36N4O.C27H32N4O3.C26H30F2N4.C26H32N4O2/c1-2-34(15-16-35-13-11-31-12-14-35)21-23-6-3-7-24(17-23)27-9-10-32-28(33-27)8-4-5-22-18-25(29)20-26(30)19-22;1-2-32(20-23-8-3-4-9-23)21-24-12-5-13-25(18-24)27-16-17-30-28(31-27)15-7-11-22-10-6-14-26(29)19-22;1-3-32(25-13-16-29-17-14-25)21-23-9-4-10-24(19-23)27-15-18-30-28(31-27)12-6-8-22-7-5-11-26(20-22)33-2;32-24-10-7-20(8-11-24)3-2-6-26-29-14-13-25(30-26)22-5-1-4-21(17-22)19-31-16-15-28-18-23(31)9-12-27(33)34;1-18-19(2)32(12-11-29-18)17-21-6-3-7-22(13-21)25-9-10-30-26(31-25)8-4-5-20-14-23(27)16-24(28)15-20;1-19-17-27-13-14-30(19)18-21-6-3-7-22(15-21)23-11-12-28-26(29-23)8-4-5-20-9-10-25(32-2)24(31)16-20/h3,6-7,9-10,17-20,31H,2,4-5,8,11-16,21H2,1H3;5-6,10,12-14,16-19,23H,2-4,7-9,11,15,20-21H2,1H3;4-5,7,9-11,15,18-20,25,29H,3,6,8,12-14,16-17,21H2,1-2H3;1,4-5,7-8,10-11,13-14,17,23,28,32H,2-3,6,9,12,15-16,18-19H2,(H,33,34);3,6-7,9-10,13-16,18-19,29H,4-5,8,11-12,17H2,1-2H3;3,6-7,9-12,15-16,19,27,31H,4-5,8,13-14,17-18H2,1-2H3/t;;;;;19-/m.....0/s1
InChIKeyJTDIPBQCTVABCJ-IUBGKRGVSA-N
MW2685.54 g/mol
LogP27.96
Rot. Bonds56

About N-(cyclopentylmethyl)-N-[[3-[2-[3-(3-fluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]ethanamine;2-[3-(3,5-difluorophenyl)propyl]-4-[3-[(2,3-dimethylpiperazin-1-yl)methyl]phenyl]pyrimidine;N-[[3-[2-[3-(3,5-difluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]-N-ethyl-2-piperazin-1-ylethanamine;N-ethyl-N-[[3-[2-[3-(3-methoxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;3-[1-[[3-[2-[3-(4-hydroxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperazin-2-yl]propanoic acid;2-methoxy-5-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol

N-(cyclopentylmethyl)-N-[[3-[2-[3-(3-fluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]ethanamine;2-[3-(3,5-difluorophenyl)propyl]-4-[3-[(2,3-dimethylpiperazin-1-yl)methyl]phenyl]pyrimidine;N-[[3-[2-[3-(3,5-difluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]-N-ethyl-2-piperazin-1-ylethanamine;N-ethyl-N-[[3-[2-[3-(3-methoxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;3-[1-[[3-[2-[3-(4-hydroxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperazin-2-yl]propanoic acid;2-methoxy-5-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol (PubChem CID 159016376) has the molecular formula C163H199F5N24O6 and a molecular weight of 2685.54 g/mol. Its IUPAC name is N-(cyclopentylmethyl)-N-[[3-[2-[3-(3-fluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]ethanamine;2-[3-(3,5-difluorophenyl)propyl]-4-[3-[(2,3-dimethylpiperazin-1-yl)methyl]phenyl]pyrimidine;N-[[3-[2-[3-(3,5-difluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]-N-ethyl-2-piperazin-1-ylethanamine;N-ethyl-N-[[3-[2-[3-(3-methoxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;3-[1-[[3-[2-[3-(4-hydroxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperazin-2-yl]propanoic acid;2-methoxy-5-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol.

Molecular Properties

Compound NameN-(cyclopentylmethyl)-N-[[3-[2-[3-(3-fluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]ethanamine;2-[3-(3,5-difluorophenyl)propyl]-4-[3-[(2,3-dimethylpiperazin-1-yl)methyl]phenyl]pyrimidine;N-[[3-[2-[3-(3,5-difluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]-N-ethyl-2-piperazin-1-ylethanamine;N-ethyl-N-[[3-[2-[3-(3-methoxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;3-[1-[[3-[2-[3-(4-hydroxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperazin-2-yl]propanoic acid;2-methoxy-5-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol
PubChem CID159016376
Molecular FormulaC163H199F5N24O6
Molecular Weight2685.54 g/mol
Exact Mass2683.59
IUPAC NameN-(cyclopentylmethyl)-N-[[3-[2-[3-(3-fluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]ethanamine;2-[3-(3,5-difluorophenyl)propyl]-4-[3-[(2,3-dimethylpiperazin-1-yl)methyl]phenyl]pyrimidine;N-[[3-[2-[3-(3,5-difluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]-N-ethyl-2-piperazin-1-ylethanamine;N-ethyl-N-[[3-[2-[3-(3-methoxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;3-[1-[[3-[2-[3-(4-hydroxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperazin-2-yl]propanoic acid;2-methoxy-5-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol
SMILESCC1NCCN(Cc2cccc(-c3ccnc(CCCc4cc(F)cc(F)c4)n3)c2)C1C.CCN(CCN1CCNCC1)Cc1cccc(-c2ccnc(CCCc3cc(F)cc(F)c3)n2)c1.CCN(Cc1cccc(-c2ccnc(CCCc3cccc(F)c3)n2)c1)CC1CCCC1.CCN(Cc1cccc(-c2ccnc(CCCc3cccc(OC)c3)n2)c1)C1CCNCC1.COc1ccc(CCCc2nccc(-c3cccc(CN4CCNC[C@@H]4C)c3)n2)cc1O.O=C(O)CCC1CNCCN1Cc1cccc(-c2ccnc(CCCc3ccc(O)cc3)n2)c1
InChIInChI=1S/C28H35F2N5.C28H34FN3.C28H36N4O.C27H32N4O3.C26H30F2N4.C26H32N4O2/c1-2-34(15-16-35-13-11-31-12-14-35)21-23-6-3-7-24(17-23)27-9-10-32-28(33-27)8-4-5-22-18-25(29)20-26(30)19-22;1-2-32(20-23-8-3-4-9-23)21-24-12-5-13-25(18-24)27-16-17-30-28(31-27)15-7-11-22-10-6-14-26(29)19-22;1-3-32(25-13-16-29-17-14-25)21-23-9-4-10-24(19-23)27-15-18-30-28(31-27)12-6-8-22-7-5-11-26(20-22)33-2;32-24-10-7-20(8-11-24)3-2-6-26-29-14-13-25(30-26)22-5-1-4-21(17-22)19-31-16-15-28-18-23(31)9-12-27(33)34;1-18-19(2)32(12-11-29-18)17-21-6-3-7-22(13-21)25-9-10-30-26(31-25)8-4-5-20-14-23(27)16-24(28)15-20;1-19-17-27-13-14-30(19)18-21-6-3-7-22(15-21)23-11-12-28-26(29-23)8-4-5-20-9-10-25(32-2)24(31)16-20/h3,6-7,9-10,17-20,31H,2,4-5,8,11-16,21H2,1H3;5-6,10,12-14,16-19,23H,2-4,7-9,11,15,20-21H2,1H3;4-5,7,9-11,15,18-20,25,29H,3,6,8,12-14,16-17,21H2,1-2H3;1,4-5,7-8,10-11,13-14,17,23,28,32H,2-3,6,9,12,15-16,18-19H2,(H,33,34);3,6-7,9-10,13-16,18-19,29H,4-5,8,11-12,17H2,1-2H3;3,6-7,9-12,15-16,19,27,31H,4-5,8,13-14,17-18H2,1-2H3/t;;;;;19-/m.....0/s1
InChIKeyJTDIPBQCTVABCJ-IUBGKRGVSA-N
XLogP27.96
TPSA333.73 Ų
H-Bond Donors8
H-Bond Acceptors29
Rotatable Bonds56
Heavy Atoms198
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002685.54
LogP ≤ 527.96
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1029

Analyze N-(cyclopentylmethyl)-N-[[3-[2-[3-(3-fluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]ethanamine;2-[3-(3,5-difluorophenyl)propyl]-4-[3-[(2,3-dimethylpiperazin-1-yl)methyl]phenyl]pyrimidine;N-[[3-[2-[3-(3,5-difluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]-N-ethyl-2-piperazin-1-ylethanamine;N-ethyl-N-[[3-[2-[3-(3-methoxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;3-[1-[[3-[2-[3-(4-hydroxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperazin-2-yl]propanoic acid;2-methoxy-5-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(cyclopentylmethyl)-N-[[3-[2-[3-(3-fluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]ethanamine;2-[3-(3,5-difluorophenyl)propyl]-4-[3-[(2,3-dimethylpiperazin-1-yl)methyl]phenyl]pyrimidine;N-[[3-[2-[3-(3,5-difluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]-N-ethyl-2-piperazin-1-ylethanamine;N-ethyl-N-[[3-[2-[3-(3-methoxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;3-[1-[[3-[2-[3-(4-hydroxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperazin-2-yl]propanoic acid;2-methoxy-5-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol?
The IUPAC name of N-(cyclopentylmethyl)-N-[[3-[2-[3-(3-fluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]ethanamine;2-[3-(3,5-difluorophenyl)propyl]-4-[3-[(2,3-dimethylpiperazin-1-yl)methyl]phenyl]pyrimidine;N-[[3-[2-[3-(3,5-difluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]-N-ethyl-2-piperazin-1-ylethanamine;N-ethyl-N-[[3-[2-[3-(3-methoxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;3-[1-[[3-[2-[3-(4-hydroxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperazin-2-yl]propanoic acid;2-methoxy-5-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol (CID 159016376) is N-(cyclopentylmethyl)-N-[[3-[2-[3-(3-fluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]ethanamine;2-[3-(3,5-difluorophenyl)propyl]-4-[3-[(2,3-dimethylpiperazin-1-yl)methyl]phenyl]pyrimidine;N-[[3-[2-[3-(3,5-difluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]-N-ethyl-2-piperazin-1-ylethanamine;N-ethyl-N-[[3-[2-[3-(3-methoxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;3-[1-[[3-[2-[3-(4-hydroxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperazin-2-yl]propanoic acid;2-methoxy-5-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol.
What is the SMILES notation for N-(cyclopentylmethyl)-N-[[3-[2-[3-(3-fluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]ethanamine;2-[3-(3,5-difluorophenyl)propyl]-4-[3-[(2,3-dimethylpiperazin-1-yl)methyl]phenyl]pyrimidine;N-[[3-[2-[3-(3,5-difluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]-N-ethyl-2-piperazin-1-ylethanamine;N-ethyl-N-[[3-[2-[3-(3-methoxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;3-[1-[[3-[2-[3-(4-hydroxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperazin-2-yl]propanoic acid;2-methoxy-5-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol?
The canonical SMILES for N-(cyclopentylmethyl)-N-[[3-[2-[3-(3-fluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]ethanamine;2-[3-(3,5-difluorophenyl)propyl]-4-[3-[(2,3-dimethylpiperazin-1-yl)methyl]phenyl]pyrimidine;N-[[3-[2-[3-(3,5-difluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]-N-ethyl-2-piperazin-1-ylethanamine;N-ethyl-N-[[3-[2-[3-(3-methoxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;3-[1-[[3-[2-[3-(4-hydroxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperazin-2-yl]propanoic acid;2-methoxy-5-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol is CC1NCCN(Cc2cccc(-c3ccnc(CCCc4cc(F)cc(F)c4)n3)c2)C1C.CCN(CCN1CCNCC1)Cc1cccc(-c2ccnc(CCCc3cc(F)cc(F)c3)n2)c1.CCN(Cc1cccc(-c2ccnc(CCCc3cccc(F)c3)n2)c1)CC1CCCC1.CCN(Cc1cccc(-c2ccnc(CCCc3cccc(OC)c3)n2)c1)C1CCNCC1.COc1ccc(CCCc2nccc(-c3cccc(CN4CCNC[C@@H]4C)c3)n2)cc1O.O=C(O)CCC1CNCCN1Cc1cccc(-c2ccnc(CCCc3ccc(O)cc3)n2)c1.
What is the InChIKey of N-(cyclopentylmethyl)-N-[[3-[2-[3-(3-fluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]ethanamine;2-[3-(3,5-difluorophenyl)propyl]-4-[3-[(2,3-dimethylpiperazin-1-yl)methyl]phenyl]pyrimidine;N-[[3-[2-[3-(3,5-difluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]-N-ethyl-2-piperazin-1-ylethanamine;N-ethyl-N-[[3-[2-[3-(3-methoxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;3-[1-[[3-[2-[3-(4-hydroxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperazin-2-yl]propanoic acid;2-methoxy-5-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol?
The InChIKey is JTDIPBQCTVABCJ-IUBGKRGVSA-N. The full InChI is InChI=1S/C28H35F2N5.C28H34FN3.C28H36N4O.C27H32N4O3.C26H30F2N4.C26H32N4O2/c1-2-34(15-16-35-13-11-31-12-14-35)21-23-6-3-7-24(17-23)27-9-10-32-28(33-27)8-4-5-22-18-25(29)20-26(30)19-22;1-2-32(20-23-8-3-4-9-23)21-24-12-5-13-25(18-24)27-16-17-30-28(31-27)15-7-11-22-10-6-14-26(29)19-22;1-3-32(25-13-16-29-17-14-25)21-23-9-4-10-24(19-23)27-15-18-30-28(31-27)12-6-8-22-7-5-11-26(20-22)33-2;32-24-10-7-20(8-11-24)3-2-6-26-29-14-13-25(30-26)22-5-1-4-21(17-22)19-31-16-15-28-18-23(31)9-12-27(33)34;1-18-19(2)32(12-11-29-18)17-21-6-3-7-22(13-21)25-9-10-30-26(31-25)8-4-5-20-14-23(27)16-24(28)15-20;1-19-17-27-13-14-30(19)18-21-6-3-7-22(15-21)23-11-12-28-26(29-23)8-4-5-20-9-10-25(32-2)24(31)16-20/h3,6-7,9-10,17-20,31H,2,4-5,8,11-16,21H2,1H3;5-6,10,12-14,16-19,23H,2-4,7-9,11,15,20-21H2,1H3;4-5,7,9-11,15,18-20,25,29H,3,6,8,12-14,16-17,21H2,1-2H3;1,4-5,7-8,10-11,13-14,17,23,28,32H,2-3,6,9,12,15-16,18-19H2,(H,33,34);3,6-7,9-10,13-16,18-19,29H,4-5,8,11-12,17H2,1-2H3;3,6-7,9-12,15-16,19,27,31H,4-5,8,13-14,17-18H2,1-2H3/t;;;;;19-/m.....0/s1.
What are the key properties of N-(cyclopentylmethyl)-N-[[3-[2-[3-(3-fluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]ethanamine;2-[3-(3,5-difluorophenyl)propyl]-4-[3-[(2,3-dimethylpiperazin-1-yl)methyl]phenyl]pyrimidine;N-[[3-[2-[3-(3,5-difluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]-N-ethyl-2-piperazin-1-ylethanamine;N-ethyl-N-[[3-[2-[3-(3-methoxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;3-[1-[[3-[2-[3-(4-hydroxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperazin-2-yl]propanoic acid;2-methoxy-5-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol?
N-(cyclopentylmethyl)-N-[[3-[2-[3-(3-fluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]ethanamine;2-[3-(3,5-difluorophenyl)propyl]-4-[3-[(2,3-dimethylpiperazin-1-yl)methyl]phenyl]pyrimidine;N-[[3-[2-[3-(3,5-difluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]-N-ethyl-2-piperazin-1-ylethanamine;N-ethyl-N-[[3-[2-[3-(3-methoxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;3-[1-[[3-[2-[3-(4-hydroxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperazin-2-yl]propanoic acid;2-methoxy-5-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol has a molecular weight of 2685.54 g/mol, XLogP of 27.96, 56 rotatable bonds, 8 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for N-(cyclopentylmethyl)-N-[[3-[2-[3-(3-fluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]ethanamine;2-[3-(3,5-difluorophenyl)propyl]-4-[3-[(2,3-dimethylpiperazin-1-yl)methyl]phenyl]pyrimidine;N-[[3-[2-[3-(3,5-difluorophenyl)propyl]pyrimidin-4-yl]phenyl]methyl]-N-ethyl-2-piperazin-1-ylethanamine;N-ethyl-N-[[3-[2-[3-(3-methoxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;3-[1-[[3-[2-[3-(4-hydroxyphenyl)propyl]pyrimidin-4-yl]phenyl]methyl]piperazin-2-yl]propanoic acid;2-methoxy-5-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol is sourced from PubChem (CID 159016376), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).